COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 285: Articles 2841-2850  | Next

SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback
Coelho, C. H., Bloom, N., Ramirez, S. I., Parikh, U. M., Heaps, A., Sieg, S. F., Greninger, A., Ritz, J., Moser, C., Eron, J. J., Currier, J. S., Klekotka, P., Wohl, D. A., Daar, E. S., Li, J., Hughes, M. D., Chew, K. W., Smith, D. M., Crotty, S., Accelerating COVID-19 Therapeutic Interventions and Vaccines: 2/A5401 (ACTIV-2/A5401) Study Team
10.1101/2023.11.21.567575 — Posted: 2023-11-22
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates
Moliva, J. I., Andrew, S. F., Flynn, B. J., Wagner, D. A., Foulds, K. E., Gagne, M., Flebbe, D. R., Lamb, E., Provost, S., Marquez, J., Mychalowych, A., Lorag, C., Honeycutt, C. C., Burnett, M. R., McCormick, L., Henry, A. R., Godbole, S., Davis-Gardner, M. E., Minai, M., Bok, K. W., Nagata, B. M., Todd, J.-P. M., McCarthy, E., Dodson, A., Kouneski, K., Cook, A., Pessaint, L., Van Ry, A., Valentin, D., Young, S., Littman, Y., Boon, A. C. M., Suthar, M. S., Lewis, M. G., Andersen, H., Alves, D. A., Woodward, R., Leuzzi, A., Vitelli, A., Colloca, S., Folgori, A., Raggiolli, A., Capone, S., Nason, M. C., Douek, D., Roederer, M., Seder, R. A., Sullivan, N. J.
10.1101/2023.11.22.567930 — Posted: 2023-11-22
Using the Public Health and Social Measures Severity Index for analysing government responses during the COVID-19 pandemic in the WHO European Region
Wippel, C., Owen, L., Cocciolone, D., Sane, J., Addo, J., Gapp, C., Latta, A. L., Lindmark, S., Perehinets, I., Smallwood, C., Schmidt, T.
10.1101/2023.11.21.23298818 — Posted: 2023-11-22
Audiovestibular adverse events following COVID-19 vaccinations
Shetty, A. N., Morgan, H. J., Phuong, L. K., Mallard, J., Vlasenko, D., Pearce, C., Crawford, N. W., Buttery, J. P., Clothier, H. J.
10.1101/2023.11.13.23298435 — Posted: 2023-11-22
Hematologic abnormalities after COVID-19 vaccination: A large Korean population-based cohort study
CHOI, H. S., KIM, M.-H., CHOI, M. G., PARK, J. H., CHUN, E. M.
10.1101/2023.11.15.23298565 — Posted: 2023-11-22
The spectrum of non-fatal immune-related adverse events following COVID-19 vaccination: The population-based cohort study in Seoul, South Korea
Suh, J. H., Kim, H. J., Kim, M.-H., Choi, M. G., Chun, E. M.
10.1101/2023.11.15.23298566 — Posted: 2023-11-22
Correlation between COVID-19 vaccination and inflammatory musculoskeletal disorders
Park, Y. H., Kim, M. H., Choi, M. G., Chun, E. M.
10.1101/2023.11.14.23298544 — Posted: 2023-11-22
Public Health and Social Measures (PHSM) interventions to control COVID-19: A Protocol for an Overview of Systematic Reviews
Fadlallah, R., El-Jardali, F., Bou Karroum, L., Kalach, N., Hoteit, R., Aoun, A., Al-Hakim, L., Verdugo-Paiva, F., Rada, G., Fretheim, A., Lewin, S., Ludolph, R., Akl, E.
10.1101/2023.11.21.23298387 — Posted: 2023-11-22
Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort Study
Vos, E. R. A., van Hagen, C. C. E., Wong, D., Smits, G., Kuijer, M., Wijmenga-Monsuur, A. J., Kaczorowska, J., van Binnendijk, R. S., van der Klis, F. R. M., den Hartog, G., de Melker, H. E.
10.1101/2023.11.22.23298889 — Posted: 2023-11-22
CLUSTER ANALYSIS IDENTIFIES LONG COVID SUBTYPES IN BELGIAN PATIENTS
Mfouth Kemajou, P., Besse-Hammer, T., Lebouc, C., Coppieters, Y.
10.1101/2023.11.22.23298807 — Posted: 2023-11-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).